IL33 and neoplasm: According to this data together with antecedents that attribute an anti-tumorigenic role to ST2 in murine models (38, 44), we suggest that ST2 could have a protective role on early stages of tumor progression, particularly in left colon and specially soluble ST2, which might neutralize IL-33.